Assessing sample representativeness in randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network

被引:50
作者
Susukida, Ryoko [1 ]
Crum, Rosa M. [1 ,2 ,3 ]
Stuart, Elizabeth A. [1 ]
Ebnesajjad, Cyrus [1 ]
Mojtabai, Ramin [1 ,3 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, 624 North Broadway Room 897, Baltimore, MD 21205 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA
关键词
Clinical trials; sample representativeness; substance use disorders; MOTIVATIONAL ENHANCEMENT THERAPY; BUPRENORPHINE-NALOXONE; SOCIOECONOMIC-STATUS; SUBSTANCE-ABUSE; GENERALIZABILITY; DEPENDENCE; INCENTIVES; PREDICTORS; EDUCATION; SELECTION;
D O I
10.1111/add.13327
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims To compare the characteristics of individuals participating in randomized controlled trials (RCTs) of treatments of substance use disorder (SUD) with individuals receiving treatment in usual care settings, and to provide a summary quantitative measure of differences between characteristics of these two groups of individuals using propensity score methods. Design Analyses using data from RCT samples from the National Institute of Drug Abuse Clinical Trials Network (CTN) and target populations of patients drawn from the Treatment Episodes Data Set-Admissions (TEDS-A). Settings Multiple clinical trial sites and nation-wide usual SUD treatment settings in the United States. Participants A total of 3592 individuals from 10 CTN samples and 1 602 226 individuals selected from TEDS-A between 2001 and 2009. Measurements The propensity scores for enrolling in the RCTs were computed based on the following nine observable characteristics: sex, race/ethnicity, age, education, employment status, marital status, admission to treatment through criminal justice, intravenous drug use and the number of prior treatments. Findings The proportion of those with >= 12 years of education and the proportion of those who had full-time jobs were significantly higher among RCT samples than among target populations (in seven and nine trials, respectively, at P < 0.001). The pooled difference in the mean propensity scores between the RCTs and the target population was 1.54 standard deviations and was statistically significant at P < 0.001. Conclusions In the United States, individuals recruited into randomized controlled trials of substance use disorder treatments appear to be very different from individuals receiving treatment in usual care settings. Notably, RCT participants tend to have more years of education and a greater likelihood of full-time work compared with people receiving care in usual care settings.
引用
收藏
页码:1226 / 1234
页数:9
相关论文
共 50 条
[41]   Assessing Clinical Effects of Traditional Chinese Medicine Interventions: Moving Beyond Randomized Controlled Trials [J].
Sun, Xin ;
Li, Ling ;
Liu, Yanmei ;
Wang, Wen ;
Yao, Minghong ;
Tan, Jing ;
Ren, Yan ;
Deng, Ke ;
Ma, Yu ;
Wang, Yuning ;
Chen, Jin ;
Huang, Wei ;
Xia, Qing ;
Li, Youping ;
Shang, Hongcai .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[42]   A Vector Theory of Assessing Clinical Trials: An Application to Bioequivalence [J].
Karalis, Vangelis D. .
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (07)
[43]   Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study [J].
Weiss, Roger D. ;
Potter, Jennifer Sharpe ;
Griffin, Margaret L. ;
Provost, Scott E. ;
Fitzmaurice, Garrett M. ;
McDermott, Katherine A. ;
Srisarajivakul, Emily N. ;
Dodd, Dorian R. ;
Dreifuss, Jessica A. ;
McHugh, R. Kathryn ;
Carroll, Kathleen M. .
DRUG AND ALCOHOL DEPENDENCE, 2015, 150 :112-119
[44]   Assessing non-consent bias with parallel randomized and nonrandomized clinical trials [J].
Marcus, SM .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (07) :823-828
[45]   Representativeness of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Trial Participants [J].
Kaur, Manmeet ;
Horowitz, Mary M. ;
Mendizabal, Adam ;
Chen, Min ;
Foley, Amy ;
Auletta, Jeffery J. ;
Devine, Steven ;
D'Souza, Anita .
TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (01) :49-57
[46]   Virtual controls as an alternative to randomized controlled trials for assessing efficacy of interventions [J].
Strayhorn, Joseph M., Jr. .
BMC MEDICAL RESEARCH METHODOLOGY, 2021, 21 (01)
[47]   Assessing heterogeneity in treatment initiation guidelines in longitudinal randomized controlled trials [J].
Cho, Hyunkeun Ryan ;
Kim, Seonjin .
JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2025, 235
[48]   Lessons learned and future directions: A scoping review of American Indian and Alaska Native participants in the National Drug Abuse Treatment Clinical Trials Network [J].
Crouch, Maria C. ;
Venner, Kamilla L. ;
Wendt, Dennis C. ;
Burlew, Ann Kathleen ;
Baukol, Paulette ;
Funaro, Melissa C. ;
Sorrell, Tanya ;
Haeny, Angela M. .
JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2023, 153
[49]   Examining the factor structure of the Clinical Opiate Withdrawal Scale: A secondary data analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003 [J].
Barbosa-Leiker, Celestina ;
McPherson, Sterling ;
Mamey, Mary Rose ;
Burns, G. Leonard ;
Layton, Matthew E. ;
Roll, John ;
Ling, Walter .
DRUG AND ALCOHOL DEPENDENCE, 2015, 152 :218-223
[50]   Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial [J].
Weir, Isabelle R. ;
Dufault, Suzanne M. ;
Phillips, Patrick P. J. .
TRIALS, 2024, 25 (01)